Filing Flows › Citius Pharmaceuticals (CTXR) › Q2 FY26 › vs Q1 FY26
Citius Pharmaceuticals (CTXR) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Citius Pharmaceuticals's revenue fell $2.3M (-58%) from $3.9M in Q1 FY26 to $1.7M in Q2 FY26.
Citius Pharmaceuticals, Q2 FY26: revenue $1.7M, net loss $28.1M, operating cash flow −$1.3M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7M | $3.9M | −$2.3M | -58% |
| Other income, net | $3.9M | −$110K | $4.0M | — |
| Income tax benefit | $231K | −$264K | $495K | — |
| Net loss | $28.1M | $9.4M | $18.7M | +199% |
| Costs & expenses | $33.9M | $13.3M | $20.5M | +154% |
| Operating costs | $33.9M | $13.0M | $20.9M | +161% |
| Cost of revenue | $329K | $789K | −$460K | -58% |
| Research & development | $1.6M | $1.6M | $34K | +2% |
| General & admin | $26.4M | $5.7M | $20.7M | +361% |
| Other operating costs | $5.5M | $4.9M | $655K | +13% |
| Operating cash sources | $28.1M | $9.4M | $18.7M | +199% |
| Share-based compensation | $3.8M | $4.3M | −$492K | -11% |
| Working capital & other | $23.0M | −$7.9M | $30.9M | — |
| Cash used in operations | $1.3M | $13.0M | −$11.7M | -90% |
| Net loss absorbed | $28.1M | $9.4M | $18.7M | +199% |
Questions
How much did Citius Pharmaceuticals's revenue grow quarter over quarter in Q2 FY26?
Citius Pharmaceuticals's revenue fell $2.3M (-58%) from $3.9M in Q1 FY26 to $1.7M in Q2 FY26.